Alpine Immune Sciences, Inc. (ALPN): Price and Financial Metrics
ALPN Price/Volume Stats
Current price | $64.97 | 52-week high | $65.00 |
Prev. close | $64.96 | 52-week low | $8.33 |
Day low | $64.97 | Volume | 4,288,300 |
Day high | $65.00 | Avg. volume | 1,917,072 |
50-day MA | $52.49 | Dividend yield | N/A |
200-day MA | $26.27 | Market Cap | 4.46B |
ALPN Stock Price Chart Interactive Chart >
Alpine Immune Sciences, Inc. (ALPN) Company Bio
Alpine Immune Sciences, Inc. is focused on developing novel protein‐based immunotherapies using its proprietary Variant Ig Domain vIgD platform technology. The vIgD platform is designed to interact with multiple targets, including many present in the immune synapse. Alpine’s vIgDs are developed using a process known as directed evolution, which can potentially produce proteins capable of either enhancing or diminishing an immune response and thereby may potentially apply therapeutically to both oncology and inflammatory diseases. The company formed following a July, 2017 merger with Nivalis Therapeutics.
ALPN Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | N/A |
5-year | N/A |
YTD | N/A |
2023 | N/A |
2022 | N/A |
2021 | N/A |
2020 | N/A |
2019 | N/A |
Continue Researching ALPN
Want to do more research on Alpine Immune Sciences Inc's stock and its price? Try the links below:Alpine Immune Sciences Inc (ALPN) Stock Price | Nasdaq
Alpine Immune Sciences Inc (ALPN) Stock Quote, History and News - Yahoo Finance
Alpine Immune Sciences Inc (ALPN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...